Clinical Trial Update: MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial) [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating montelukast as a potential chondroprotective treatment after ACL reconstruction; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Injury
• Meniscal Tear
• Post-traumatic Osteoarthritis

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Austin V Stone | Conditions: ACL Injury, Meniscus Tear | EARLY_Phase 1 | Status: RECRUITING